$1.5 billion Abbott fine shows government more serious about penalizing off-label promotion

Off-label promotion is apparently second nature to healthcare companies. Even despite  the fact that it is illegal. Now there may be a powerful deterrent and a signal that the federal government…
Read the full story: MedCity News